Pheast Therapeutics, Inc. filed a Form D with the Securities and Exchange Commission on 2025-10-16.
Pheast Therapeutics, Inc. filed a Form D notice of an exempt securities offering with the SEC on October 16, 2025. The filing reports $24.59M sold. Its industry group is Other Technology. It names Roy Maute (Executive Officer, Director), Amira Barkal (Director), Steven Gillis (Director) (SEC Form D, October 16, 2025).
Is this your company?
Sell to companies like Pheast Therapeutics, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-10-16 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Pheast Therapeutics, Inc.
Free to see. No signup.
More on the people and the money behind Pheast Therapeutics, Inc., from the filings we hold.
Other Technology raises by companies based in California, filed in October 2025, largest first.
Get an email when Pheast Therapeutics, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Pheast Therapeutics, Inc. raises, hires or launches. No email unless you switch it on.
Watch Pheast Therapeutics, Inc. →Get the full cited report on Pheast Therapeutics, Inc.
What the filing shows about Pheast Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Pheast Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Pheast Therapeutics, Inc.'s address as 200 Cardinal Way, Ste 300, Redwood City, CA 94063.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Pheast Therapeutics, Inc. See pricing
Pheast Therapeutics, Inc. is a registered filer with the SEC (CIK 1943737) and has filed since 2022-10-28. 3 filings are on record, the latest on 2025-10-16.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Pheast Therapeutics, Inc.'s Form D of 2025-10-16 names Roy Maute, Amira Barkal, Steven Gillis and 4 more as its officers, directors or promoters.
Its new offerings report $49.81M sold across 2 offerings, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 3844 filings in Other Technology, totalled by week.
Roy Maute is named as Executive Officer and Director on the Form D that Pheast Therapeutics, Inc. filed with the SEC on 16 October 2025, one of 7 people that filing names.
Amira Barkal is named as Director on the Form D that Pheast Therapeutics, Inc. filed with the SEC on 16 October 2025, one of 7 people that filing names.
Steven Gillis is named as Director on the Form D that Pheast Therapeutics, Inc. filed with the SEC on 16 October 2025, one of 7 people that filing names.
Jacob Vogelstein is named as Director on the Form D that Pheast Therapeutics, Inc. filed with the SEC on 16 October 2025, one of 7 people that filing names.
Thomas Marty is named as Executive Officer on the Form D that Pheast Therapeutics, Inc. filed with the SEC on 16 October 2025, one of 7 people that filing names.
Raphael Rousseau is named as Executive Officer on the Form D that Pheast Therapeutics, Inc. filed with the SEC on 16 October 2025, one of 7 people that filing names.
Irving Weissman is named as Director on the Form D that Pheast Therapeutics, Inc. filed with the SEC on 16 October 2025, one of 7 people that filing names.
7 people named on the filing — 3 holding an executive role and 4 as directors only.
Named as of the 2025-10-16 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Pheast Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Pheast Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Pheast Therapeutics, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Pheast Therapeutics, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Pheast Therapeutics, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Pheast Therapeutics, Inc.. With no account yet, you sign up free and land on the result.
On these lists: AI and software raises in San Francisco Bay Area
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/pheast-therapeutics-inc-form-d-25000001